NCT01293448 - Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Barrett's EsophagusEsophageal Cancer

Interventions

DEVICE

Cryoballoon Ablation

"Device: CryoBalloon Ablation System(TM) C2 Therapeutics Inc. received FDA market clearance for the CryoBalloon Ablation System on September 29, 2010. The System is a Class II device intended to be used as a cryosurgical tool for the destruction of unwanted tissue in the field of general surgery, specifically for endoscopic applications. (K101825)"

Trial Locations (4)

1105

AMC, Amsterdam

14642

University of Rochester, Rochester

15232

University of Pittsburgh, Pittsburgh

90033

University of Southern California, Los Angeles